DOI: 10.12890/2020_001763

COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia

Authors

  • Orivaldo Alves Barbosa Hospital Geral Dr. César Cals, Fortaleza /Ceará, Brazil; Department of Medicine, Christus University Center (UNICHRISTUS), Fortaleza /Ceará, Brazil
  • Talita Guimarães Andrade Department of Medicine, Christus University Center (UNICHRISTUS), Fortaleza /Ceará, Brazil
  • Maria Danielly de Almeida Sousa Department of Medicine, Christus University Center (UNICHRISTUS), Fortaleza /Ceará, Brazil
  • José Walter Correia Department of Internal Medicine, Hospital Geral Dr. César Cals, Fortaleza /Ceará, Brazil

orivaldo.alves.barbosa@gmail.com

Keywords

Chronic lymphocytic leukaemia, COVID-19, coronavirus, pseudohypoxemia, sepsis

Abstract

Infection with SARS-CoV-2 causes critical disease in approximately 5% of affected patients, particularly the elderly, hypertensive, obese and immunocompromised. Patients with haematological cancer, including chronic lymphocytic leukaemia (CLL), are particularly at risk of complications. Very rarely, patients with extreme leukocytosis may develop spurious hypoxemia, or pseudohypoxemia, which confuses the diagnosis of complications and can lead to intervention errors. We report the case of a patient with CLL, severe infection with SARS-CoV-2 and pseudohypoxemia.

View the entire article

Downloads

Published

2020-06-11

Issue

Vol. 7 No. 7 (2020)

Categories

How to Cite

1.
Alves Barbosa O, Guimarães Andrade T, de Almeida Sousa MD, Correia JW. COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia. EJCRIM [Internet]. 2020 Jun. 11 [cited 2026 Nov. 3];7(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1763